iBio, Inc. (IBIO)
Nasdaq: IBIO · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2008
The company now
iBio, Inc. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in New York, NY. In its latest annual figures on file, for the fiscal year ended 2026-06-30, it reported revenue of $100 thousand and a loss of $33 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.